APO Research
Talk to an analyst

APO RESEARCH · REPORT

Coagulation Factor IX

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Coagulation Factor IX Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025184 pages

Choose your research edition.

Industry ResearchCoagulation Factor IX Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Coagulation Factor IX Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Coagulation Factor IX Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coagulation Factor IX Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Coagulation Factor IX Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Coagulation Factor IX market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Coagulation Factor IX is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Coagulation Factor IX is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Coagulation Factor IX is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Coagulation Factor IX is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Coagulation Factor IX include Takeda, Novo Nordisk, Pfizer, Baxter, Sanquin, Grifols, CSL Behring, Bioverativ and Aptevo, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Coagulation Factor IX market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Coagulation Factor IX and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Coagulation Factor IX sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Coagulation Factor IX market size, projected growth trends, production technologies, key applications, and end-use industries.

Coagulation Factor IX Segment by Company

Takeda

Novo Nordisk

Pfizer

Baxter

Sanquin

Grifols

CSL Behring

Bioverativ

Aptevo

Coagulation Factor IX Segment by Type

Coagulation Factor IX (Plasma Derived)

Coagulation Factor IX (Recombinant)

Coagulation Factor IX Segment by Application

Adult

Kids

Coagulation Factor IX Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coagulation Factor IX market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coagulation Factor IX and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coagulation Factor IX.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Coagulation Factor IX market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Coagulation Factor IX manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Coagulation Factor IX in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Coagulation Factor IX in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Coagulation Factor IX Industry Trends Table 2. Coagulation Factor IX Industry Drivers Table 3. Coagulation Factor IX Industry Opportunities and Challenges Table 4. Coagulation Factor IX Industry Restraints Table 5. Global Coagulation Factor IX Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Coagulation Factor IX Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Coagulation Factor IX Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Coagulation Factor IX Sales Market Share by Manufacturers Table 9. Global Coagulation Factor IX Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Coagulation Factor IX Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Coagulation Factor IX Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Coagulation Factor IX Manufacturers, Product Type & Application Table 13. Global Coagulation Factor IX Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Coagulation Factor IX by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Coagulation Factor IX (Plasma Derived) Table 17. Major Manufacturers of Coagulation Factor IX (Recombinant) Table 18. Global Coagulation Factor IX Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 19. Global Coagulation Factor IX Sales by Type (2021-2026) & (W Units) Table 20. Global Coagulation Factor IX Sales by Type (2027-2032) & (W Units) Table 21. Global Coagulation Factor IX Sales Market Share by Type (2021-2026) Table 22. Global Coagulation Factor IX Sales Market Share by Type (2027-2032) Table 23. Global Coagulation Factor IX Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 24. Global Coagulation Factor IX Revenue by Type (2021-2026) & (W Units) Table 25. Global Coagulation Factor IX Revenue by Type (2027-2032) & (W Units) Table 26. Global Coagulation Factor IX Revenue Market Share by Type (2021-2026) Table 27. Global Coagulation Factor IX Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Adult Table 29. Major Manufacturers of Kids Table 30. Global Coagulation Factor IX Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 31. Global Coagulation Factor IX Sales by Application (2021-2026) & (W Units) Table 32. Global Coagulation Factor IX Sales by Application (2027-2032) & (W Units) Table 33. Global Coagulation Factor IX Sales Market Share by Application (2021-2026) Table 34. Global Coagulation Factor IX Sales Market Share by Application (2027-2032) Table 35. Global Coagulation Factor IX Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 36. Global Coagulation Factor IX Revenue by Application (2021-2026) & (W Units) Table 37. Global Coagulation Factor IX Revenue by Application (2027-2032) & (W Units) Table 38. Global Coagulation Factor IX Revenue Market Share by Application (2021-2026) Table 39. Global Coagulation Factor IX Revenue Market Share by Application (2027-2032) Table 40. Global Coagulation Factor IX Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 41. Global Coagulation Factor IX Sales by Region (2021-2026) & (W Units) Table 42. Global Coagulation Factor IX Sales Market Share by Region (2021-2026) Table 43. Global Coagulation Factor IX Sales Forecasted by Region (2027-2032) & (W Units) Table 44. Global Coagulation Factor IX Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Coagulation Factor IX Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 46. North America Coagulation Factor IX Sales by Country (2021-2026) & (W Units) Table 47. North America Coagulation Factor IX Sales by Country (2027-2032) & (W Units) Table 48. Europe Coagulation Factor IX Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 49. Europe Coagulation Factor IX Sales by Country (2021-2026) & (W Units) Table 50. Europe Coagulation Factor IX Sales by Country (2027-2032) & (W Units) Table 51. Asia Pacific Coagulation Factor IX Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 52. Asia Pacific Coagulation Factor IX Sales by Country (2021-2026) & (W Units) Table 53. Asia Pacific Coagulation Factor IX Sales by Country (2027-2032) & (W Units) Table 54. South America, Middle East and Africa Coagulation Factor IX Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. South America, Middle East and Africa Coagulation Factor IX Sales by Country (2021-2026) & (W Units) Table 56. South America, Middle East and Africa Coagulation Factor IX Sales by Country (2027-2032) & (W Units) Table 57. Global Coagulation Factor IX Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Coagulation Factor IX Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Coagulation Factor IX Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Coagulation Factor IX Revenue Market Share by Region (2021-2026) Table 61. Global Coagulation Factor IX Revenue Market Share by Region (2027-2032) Table 62. Takeda Company Information Table 63. Takeda Business Overview Table 64. Takeda Coagulation Factor IX Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Takeda Coagulation Factor IX Product Portfolio Table 66. Takeda Recent Development Table 67. Novo Nordisk Company Information Table 68. Novo Nordisk Business Overview Table 69. Novo Nordisk Coagulation Factor IX Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Novo Nordisk Coagulation Factor IX Product Portfolio Table 71. Novo Nordisk Recent Development Table 72. Pfizer Company Information Table 73. Pfizer Business Overview Table 74. Pfizer Coagulation Factor IX Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Pfizer Coagulation Factor IX Product Portfolio Table 76. Pfizer Recent Development Table 77. Baxter Company Information Table 78. Baxter Business Overview Table 79. Baxter Coagulation Factor IX Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Baxter Coagulation Factor IX Product Portfolio Table 81. Baxter Recent Development Table 82. Sanquin Company Information Table 83. Sanquin Business Overview Table 84. Sanquin Coagulation Factor IX Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Sanquin Coagulation Factor IX Product Portfolio Table 86. Sanquin Recent Development Table 87. Grifols Company Information Table 88. Grifols Business Overview Table 89. Grifols Coagulation Factor IX Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Grifols Coagulation Factor IX Product Portfolio Table 91. Grifols Recent Development Table 92. CSL Behring Company Information Table 93. CSL Behring Business Overview Table 94. CSL Behring Coagulation Factor IX Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. CSL Behring Coagulation Factor IX Product Portfolio Table 96. CSL Behring Recent Development Table 97. Bioverativ Company Information Table 98. Bioverativ Business Overview Table 99. Bioverativ Coagulation Factor IX Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Bioverativ Coagulation Factor IX Product Portfolio Table 101. Bioverativ Recent Development Table 102. Aptevo Company Information Table 103. Aptevo Business Overview Table 104. Aptevo Coagulation Factor IX Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Aptevo Coagulation Factor IX Product Portfolio Table 106. Aptevo Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Coagulation Factor IX Distributors List Table 110. Coagulation Factor IX Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Coagulation Factor IX Product Image Figure 2. Global Coagulation Factor IX Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Coagulation Factor IX Market Size (2021-2032) & (US$ Million) Figure 4. Global Coagulation Factor IX Sales (2021-2032) & (W Units) Figure 5. Global Coagulation Factor IX Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Coagulation Factor IX Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Coagulation Factor IX (Plasma Derived) Image Figure 9. Coagulation Factor IX (Recombinant) Image Figure 10. Global Coagulation Factor IX Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 11. Global Coagulation Factor IX Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Coagulation Factor IX Sales Market Share by Type (2021-2032) Figure 13. Global Coagulation Factor IX Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Coagulation Factor IX Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Coagulation Factor IX Revenue Market Share by Type (2021-2032) Figure 16. Adult Image Figure 17. Kids Image Figure 18. Global Coagulation Factor IX Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 19. Global Coagulation Factor IX Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Coagulation Factor IX Sales Market Share by Application (2021-2032) Figure 21. Global Coagulation Factor IX Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 22. Global Coagulation Factor IX Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Coagulation Factor IX Revenue Market Share by Application (2021-2032) Figure 24. North America Coagulation Factor IX Sales and Growth Rate (2021-2032) & (W Units) Figure 25. North America Coagulation Factor IX Sales Market Share by Country (2021-2032) Figure 26. U.S. Coagulation Factor IX Sales and Growth Rate (2021-2032) & (W Units) Figure 27. Canada Coagulation Factor IX Sales and Growth Rate (2021-2032) & (W Units) Figure 28. Mexico Coagulation Factor IX Sales and Growth Rate (2021-2032) & (W Units) Figure 29. Europe Coagulation Factor IX Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Europe Coagulation Factor IX Sales Market Share by Country (2021-2032) Figure 31. Germany Coagulation Factor IX Sales and Growth Rate (2021-2032) & (W Units) Figure 32. France Coagulation Factor IX Sales and Growth Rate (2021-2032) & (W Units) Figure 33. U.K. Coagulation Factor IX Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Italy Coagulation Factor IX Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Netherlands Coagulation Factor IX Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Asia Pacific Coagulation Factor IX Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Asia Pacific Coagulation Factor IX Sales Market Share by Country (2021-2032) Figure 38. China Coagulation Factor IX Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Japan Coagulation Factor IX Sales and Growth Rate (2021-2032) & (W Units) Figure 40. South Korea Coagulation Factor IX Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Southeast Asia Coagulation Factor IX Sales and Growth Rate (2021-2032) & (W Units) Figure 42. India Coagulation Factor IX Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Australia Coagulation Factor IX Sales and Growth Rate (2021-2032) & (W Units) Figure 44. South America, Middle East and Africa Coagulation Factor IX Sales and Growth Rate (2021-2032) & (W Units) Figure 45. South America, Middle East and Africa Coagulation Factor IX Sales Market Share by Country (2021-2032) Figure 46. Brazil Coagulation Factor IX Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South Africa Coagulation Factor IX Sales and Growth Rate (2021-2032) & (W Units) Figure 48. Saudi Arabia Coagulation Factor IX Sales and Growth Rate (2021-2032) & (W Units) Figure 49. Turkey Coagulation Factor IX Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Argentina Coagulation Factor IX Sales and Growth Rate (2021-2032) & (W Units) Figure 51. UAE Coagulation Factor IX Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Egypt Coagulation Factor IX Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Chile Coagulation Factor IX Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Global Coagulation Factor IX Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Coagulation Factor IX Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Figure 57. North America Coagulation Factor IX Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Figure 59. Europe Coagulation Factor IX Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Coagulation Factor IX Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Coagulation Factor IX Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Coagulation Factor IX Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Coagulation Factor IX Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Coagulation Factor IX Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Coagulation Factor IX (Plasma Derived)
  • Coagulation Factor IX (Recombinant)
Applications
  • Adult
  • Kids
Companies covered
  • Takeda
  • Novo Nordisk
  • Pfizer
  • Baxter
  • Sanquin
  • Grifols
  • CSL Behring
  • Bioverativ
  • Aptevo

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Coagulation Factor IX Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Coagulation Factor IX Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Coagulation Factor IX Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Coagulation Factor IX Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Coagulation Factor IX Market Dynamics
  1. 2.1 Coagulation Factor IX Industry Trends
  2. 2.2 Coagulation Factor IX Industry Drivers
  3. 2.3 Coagulation Factor IX Industry Opportunities and Challenges
  4. 2.4 Coagulation Factor IX Industry Restraints
3 Coagulation Factor IX Market by Manufacturers
  1. 3.1 Global Coagulation Factor IX Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Coagulation Factor IX Sales by Manufacturers (2021-2026)
  3. 3.3 Global Coagulation Factor IX Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Coagulation Factor IX Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Coagulation Factor IX Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Coagulation Factor IX Manufacturers, Product Type & Application
  7. 3.7 Global Coagulation Factor IX Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Coagulation Factor IX Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Coagulation Factor IX Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Coagulation Factor IX Tier 1, Tier 2, and Tier 3
4 Coagulation Factor IX Market by Type
  1. 4.1 Coagulation Factor IX Type Introduction
  2. 4.1.1 Coagulation Factor IX (Plasma Derived)
  3. 4.1.2 Coagulation Factor IX (Recombinant)
  4. 4.2 Global Coagulation Factor IX Sales by Type
  5. 4.2.1 Global Coagulation Factor IX Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Coagulation Factor IX Sales by Type (2021-2032)
  7. 4.2.3 Global Coagulation Factor IX Sales Market Share by Type (2021-2032)
  8. 4.3 Global Coagulation Factor IX Revenue by Type
  9. 4.3.1 Global Coagulation Factor IX Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Coagulation Factor IX Revenue by Type (2021-2032)
  11. 4.3.3 Global Coagulation Factor IX Revenue Market Share by Type (2021-2032)
5 Coagulation Factor IX Market by Application
  1. 5.1 Coagulation Factor IX Application Introduction
  2. 5.1.1 Adult
  3. 5.1.2 Kids
  4. 5.2 Global Coagulation Factor IX Sales by Application
  5. 5.2.1 Global Coagulation Factor IX Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Coagulation Factor IX Sales by Application (2021-2032)
  7. 5.2.3 Global Coagulation Factor IX Sales Market Share by Application (2021-2032)
  8. 5.3 Global Coagulation Factor IX Revenue by Application
  9. 5.3.1 Global Coagulation Factor IX Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Coagulation Factor IX Revenue by Application (2021-2032)
  11. 5.3.3 Global Coagulation Factor IX Revenue Market Share by Application (2021-2032)
6 Global Coagulation Factor IX Sales by Region
  1. 6.1 Global Coagulation Factor IX Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Coagulation Factor IX Sales by Region (2021-2032)
  3. 6.2.1 Global Coagulation Factor IX Sales by Region (2021-2026)
  4. 6.2.2 Global Coagulation Factor IX Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Coagulation Factor IX Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Coagulation Factor IX Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Coagulation Factor IX Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Coagulation Factor IX Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Coagulation Factor IX Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Coagulation Factor IX Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Coagulation Factor IX Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Coagulation Factor IX Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Coagulation Factor IX Revenue by Region
  1. 7.1 Global Coagulation Factor IX Revenue by Region
  2. 7.1.1 Global Coagulation Factor IX Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Coagulation Factor IX Revenue by Region (2021-2026)
  4. 7.1.3 Global Coagulation Factor IX Revenue by Region (2027-2032)
  5. 7.1.4 Global Coagulation Factor IX Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Coagulation Factor IX Revenue (2021-2032)
  8. 7.2.2 North America Coagulation Factor IX Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Coagulation Factor IX Revenue (2021-2032)
  11. 7.3.2 Europe Coagulation Factor IX Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Coagulation Factor IX Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Coagulation Factor IX Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Coagulation Factor IX Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Coagulation Factor IX Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Coagulation Factor IX Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Novo Nordisk
  8. 8.2.1 Novo Nordisk Company Information
  9. 8.2.2 Novo Nordisk Business Overview
  10. 8.2.3 Novo Nordisk Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novo Nordisk Coagulation Factor IX Product Portfolio
  12. 8.2.5 Novo Nordisk Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Coagulation Factor IX Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Baxter
  20. 8.4.1 Baxter Company Information
  21. 8.4.2 Baxter Business Overview
  22. 8.4.3 Baxter Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Baxter Coagulation Factor IX Product Portfolio
  24. 8.4.5 Baxter Recent Developments
  25. 8.5 Sanquin
  26. 8.5.1 Sanquin Company Information
  27. 8.5.2 Sanquin Business Overview
  28. 8.5.3 Sanquin Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sanquin Coagulation Factor IX Product Portfolio
  30. 8.5.5 Sanquin Recent Developments
  31. 8.6 Grifols
  32. 8.6.1 Grifols Company Information
  33. 8.6.2 Grifols Business Overview
  34. 8.6.3 Grifols Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Grifols Coagulation Factor IX Product Portfolio
  36. 8.6.5 Grifols Recent Developments
  37. 8.7 CSL Behring
  38. 8.7.1 CSL Behring Company Information
  39. 8.7.2 CSL Behring Business Overview
  40. 8.7.3 CSL Behring Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 CSL Behring Coagulation Factor IX Product Portfolio
  42. 8.7.5 CSL Behring Recent Developments
  43. 8.8 Bioverativ
  44. 8.8.1 Bioverativ Company Information
  45. 8.8.2 Bioverativ Business Overview
  46. 8.8.3 Bioverativ Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bioverativ Coagulation Factor IX Product Portfolio
  48. 8.8.5 Bioverativ Recent Developments
  49. 8.9 Aptevo
  50. 8.9.1 Aptevo Company Information
  51. 8.9.2 Aptevo Business Overview
  52. 8.9.3 Aptevo Coagulation Factor IX Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Aptevo Coagulation Factor IX Product Portfolio
  54. 8.9.5 Aptevo Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Coagulation Factor IX Value Chain Analysis
  2. 9.1.1 Coagulation Factor IX Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Coagulation Factor IX Production Mode & Process
  6. 9.2 Coagulation Factor IX Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Coagulation Factor IX Distributors
  9. 9.2.3 Coagulation Factor IX Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst